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Quantifying the RR of harm to self and
others from substance misuse: results
from a survey of clinical experts across
Scotland
Mark Taylor,1 Kirsty Mackay,2 Jen Murphy,3 Andrew McIntosh,4 Claire McIntosh,5
Seonaid Anderson,6 Killian Welch1
ABSTRACT
Objective: To produce an expert consensus hierarchy
of harm to self and others from legal and illegal
substance use.
Design: Structured questionnaire with nine scored
categories of harm for 19 different commonly used
substances.
Setting/participants: 292 clinical experts from
across Scotland.
Results: There was no stepped categorical distinction
in harm between the different legal and illegal
substances. Heroin was viewed as the most harmful,
and cannabis the least harmful of the substances
studied. Alcohol was ranked as the fourth most
harmful substance, with alcohol, nicotine and volatile
solvents being viewed as more harmful than some
class A drugs.
Conclusions: The harm rankings of 19 commonly
used substances did not match the A, B, C
classification under the Misuse of Drugs Act. The
legality of a substance of misuse is not correlated with
its perceived harm. These results could inform any
legal review of drug misuse and help shape public
health policy and practice.
INTRODUCTION
Drug and alcohol misuse is a significant and
growing problem in Scotland. The levels of
problematic drug misuse are double that of
England, and alcohol dependency is a third
higher than other parts of the UK. Drug- and
alcohol-related deaths are among the highest
in Europe and have doubled over the past
15 years.1 In 2007, it was estimated that the
alcohol industry was worth around £3.5
billion2 and that the largest part of the
informal Scottish economy was made up
from the trade of illicit drugs. In the UK, as
a whole, the total cost burden of drug misuse
is estimated to be between £10 billion and
£16 billion per year.3
The laws regulating drug use are compli-
cated. The Misuse of Drugs Act 1971 defines
what are termed ‘controlled drugs’, dividing
illicit drugs into three categoriesdA, B, and
Cdwhich were designed to reflect the harm
caused to both the individual and society
generally by these drugs (see table 1). Drugs
classified as causing the most severe harm are
designated class A and include heroin,
cocaine and ecstasy. The law thus implies that
class A drugs are the most dangerous of all.
Class B is thought to be less harmful than
class A, but more harmful than class C and
contains amphetamines and barbiturates.
Class C includes cannabis and benzodiaze-
pine tranquillisers. This categorical classifi-
cation system does not include two commonly
used and powerful psychoactive drugs,
tobacco and alcohol, which are legal to use
for those older than 18 years in the UK.
It has been argued over recent years that
this classification has become outdated and
only modestly correlates with expert ratings
of harm caused by the various substances. In
2007, Nutt et al4 attempted to reassess the
system of drug classification and produce
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ARTICLE SUMMARY
Article focus
- To produce an expert-based consensus on the
relative harms posed by 19 commonly used legal
and illegal substances.
Key messages
- The legality of a substance is not correlated with
its perceived harm. There is no stepped ‘A, B, C’
distinction in harm evident.
Strengths and limitations of this study
- This is largest known addiction experts survey of
substance-related harm. Observer bias cannot be
excluded The availability and cost of substances
was not taken into account.
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a more contemporary hierarchy of harm. UK experts in
psychiatry, addictions and pharmacology were asked to
rate drugs on three major dimensions of harm: physical
harm, potential for dependence and social harms.
Under the physical harm dimension, they were asked to
score three different components: the acute effects and
harm to health, the chronic harm to health and the
harm to physical health caused by intravenous drug use.
Under the dependence dimension, three further
components were rated, namely the intensity of pleasure
produced by the drug, the psychological dependence
and the potential physical symptoms of dependence
related to the specific substance. In the final dimension
of social harm, the components rated were harms to
others caused by intoxication; health costs directly
resulting from the drug use, including the costs to
healthcare and social care systems; and finally, other
social harms, such as violent behaviour, neglect of chil-
dren and financial problems caused by drug use. The
aim of this study was to obtain a comprehensive
consensus from addiction experts in Scotland on the
relative harms of drug misuse, both legal and illegal
using the ranking system developed by Nutt et al.4
METHODS
Nutt et al4 designed a matrix that included three major
categories of harm with each category being subdivided
into three groups, producing nine parameters of risk.
This nine-parameter scale was adapted (see appendix) to
produce a questionnaire to assess physical and psycho-
logical harm to self and others for 19 commonly used
legal and illegal substances. The nine parameters were
(a) physical harm caused by acute, chronic and paren-
teral use; (b) psychological harm; physical harm
and intensity of pleasure linked to dependence and
(c) social harm from intoxication; other social harms
and associated healthcare costs.
The 19 substances chosen for assessment are shown in
table 1, along with their status under the Misuse of Drugs
Act at the time of this study.
Addiction specialists and psychiatrists working with
substance misuse across Scotland were approached to
complete the questionnaire, on the basis of their clinical
experience and expertise. This was mainly by face-to-face
interviews, with personal interviews being arranged via
local regional addictions teams across the country (see
the Results section for more details). Approximately 300
individuals working in multidisciplinary addiction teams
across Scotland were approached to undertake face-
to-face interviews, for completion of the questionnaire,
and were chosen via the authors’ knowledge of and
contact with local addiction services. The Royal College
of Psychiatrists in Scotland database of psychiatrists who
have a special interest in addictions (approximately 200
individuals in total) was also used to elicit completed
responses via email. The number of experts approached
was not prospectively determined beyond seeking as
large a sample size as possibledno a priori sample size
was chosen.
Guidance notes on how to complete the questionnaire
were also issued, and during the face-to-face interviews,
there was explicit guidance provided emphasising that
the harm rankings should be based on the experts’
global clinical experience of the population seen in
addictions services (ie, not based on an understanding
of ‘milder’ wider society use patterns). Participants were
asked to score each substance for each of the nine
parameters, using a 4-point scale, with 0 being no risk,
1 some risk, 2 moderate risk and 3 extreme risk.
Basic demographic information about the respon-
dents was also recorded, including region of Scotland
where they worked, specialty area of work, job title and
age. No financial or other incentive was offered to
respondents.
ANALYSIS
Scores were averaged for each parameter. For some
analyses, the scores for the three parameters for each
category were averaged to give a mean score for that
category, that is, an overall score for harm to self and
overall score for harm to others. An overall harm rating
was obtained by taking the mean of all nine scores.
RESULTS
Demographics of respondents
Two hundred and ninety-two completed responses were
obtained from seven different regions in Scotland. Fifty
per cent of respondents worked in the Glasgow region,
with 15% working in Tayside, 13% in Grampian, 11% in
Forth Valley and 9% in Lothian and Borders. One per
Table 1 Substances chosen for study and comparison
Substance
Class in Misuse of
Drugs Act at time
of data collection
Alcohol Not controlled if
over 18 years
Amphetamines B
Barbiturates B
Benzodiazepine C
Buprenorphine/Temgesic C
Cannabis B
Cocaine A
Crack cocaine A
Crystal meth A
Dihydrocodeine/codeine/Tramadol Not controlled
Ecstacy/MDTA A
Heroin A
Ketamine C
LSD A
Magic mushrooms A
Methadone A
Nicotine/tobacco Not controlled if
over 18 years
Methylphenidate/Ritalin B
Inhaled solvents Not controlled
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cent worked in Lanarkshire, and 1% of responses had
not recorded their region. Fewer than 10 psychiatrists
from the Royal College of Psychiatrists in Scotland
database submitted a completed response online. Over
90% of those directly approached for face-to-face inter-
views agreed to participate, whereas the response rate to
email requests for questionnaire completion was <5%,
perhaps reflecting that on average 30 min was required
to complete each questionnaire.
Respondents were from a range of professional back-
grounds in health and social work. They worked across
a variety of specialties with addictions being most
represented with 64% of respondents. 18.5% worked in
the General Adult Psychiatry setting and 0.5% worked in
Forensic Psychiatry. Sixteen per cent worked in other
areas such as General Practice, and 1% of respondents
had not recorded their specialty (see table 2).
The age of respondents ranged from 20 to older than
60 years. The largest groups were the 31e40 years with
38.5% and the 41e50 years with 38%. Ten per cent of
responses came from workers aged 20e30 years and 9%
from those aged 51e60 years. Four per cent of respon-
dents were aged older than 60 years and 0.5 had not
recorded their age. Addiction community psychiatric
nurses were easily the biggest single professional disci-
pline, reflecting the composition of a typical community
addictions team, and they on average had over 5 years
clinical experience in the field.
Harm rankings
The mean scores for the substances assessed are shown
in table 3. Table 3 lists the results for each of the three
subcategories of harm. The scores in each category were
averaged across all scorers, and the substances are listed
in rank order of harm based on their overall score. Many
of the drugs were consistent in their ranking across the
three categories.
Heroin, crack cocaine, crystalmeth, alcohol and cocaine
were in the top five places for all categories of harm.
LSD, ecstasy, methylphenidate, magic mushrooms and
cannabis were in the bottom five places for all categories
of harm. Cannabis was rated as the least harmful drug.
Alcohol was the only drug that rated more highly on
the social harm score than on personal harm. Alcohol
was rated fourth and nicotine was seventh across all
categories of harm ranking higher than some controlled
drugs.
Figures 1e3 are the diagrammatic representations of
the scores for each drug across the harm categories. The
colour coding equates to the drug’s status under the
Misuse of Drugs Act at the time of data collection.
DISCUSSION
The main outcome of this study is a ranking by Scottish
addiction experts of 19 recreational drugs according to
their mean harm score. The main result is that heroin,
crack cocaine, crystal meth, alcohol and cocaine were in
the top five places for all categories of harm, with LSD,
ecstasy, methylphenidate, magic mushrooms and
cannabis in the bottom five places for all categories of
harm. Notably, legal substances such as alcohol, nicotine
and volatile agents ranked as more harmful than some
class A drugs, although these drugs are more socially and
culturally embedded in Scotland than the prohibited
ones. The hierarchy of harm when judged by the experts
did not correlate with the hierarchy used currently by
the Misuse of Drugs Act. There is no indication of
a stepwise reduction in harm as would be supposed by
the current A, B, C classification and no clear delinea-
tion of scores to allow logical cut-off points for such
a categorisation. These results are similar to Nutt’s
original work and to a more recent Dutch study,5 which
used the same scoring system but different methodology
to this study. Nutt et al4 confirmed that the sharp A, B or
C division of the current classification in the UK Misuse
of Drugs Act did not correlate with the rankings of harm
Table 2 Clinical experts’ professional background
Job title Frequency Per cent
Consultant psychiatrist 24 8.2
Specialist registrar 15 5.1
SHO/staff grade 23 7.9
General practitioner 6 2.1
Addiction community
psychiatric nurse
133 45.5
Addiction worker 39 13.4
Social worker 52 17.8
Total 292 100
SHO, junior doctor.
Table 3 Assessment score tables
Substance
Personal
harm
score
Social
harm
score
Total/
combined
harm score
Heroin 2.76 2.72 2.74
Crack cocaine 2.74 2.60 2.69
Crystal meth 2.69 2.54 2.63
Alcohol 2.55 2.70 2.56
Cocaine 2.54 2.33 2.46
Inhaled solvents 2.38 2.18 2.31
Nicotine 2.42 2.23 2.29
Benzodiazepines 2.33 2.17 2.27
Ketamine 2.24 1.97 2.13
Barbiturates 2.25 1.91 2.12
Amphetamine 2.24 1.89 2.11
Methadone 2.19 1.96 2.10
Dihydrocodeine/
codeine/Tramadol
2.05 1.89 1.98
Buprenorphine 2.04 1.83 1.96
LSD 2.04 1.87 1.95
Ecstasy/MDTA 2.07 1.74 1.92
Methylphenidate/
Ritalin
1.86 1.62 1.74
Magic mushrooms 1.88 1.60 1.74
Cannabis 1.86 1.61 1.73
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by the experts, and the experts showed reasonable levels
of agreement in their rankings, leading to a proposal
that their rating system could be developed by regulatory
bodies to provide an evidence-based approach to drug
classification.
One of the strengths of this study is the large number
of experts involved. Two hundred and ninety-two
addiction multidisciplinary experts across Scotland were
involved making it the largest national panel to be
involved in this type of study. This large number of
multidisciplinary expert respondents might also help
reduce any selection and observer bias in the sample,
although it is acknowledged that the expert clinician
respondents were chosen on an ad hoc rather than
systematic basis. We obtained a high response rate for
this survey, but it is possible that addiction specialists
from geographic areas that were not approached
(eg, NHS Fife) might have reported different results,
and thus response bias cannot be excluded despite the
sample size. A recognised weakness is that the scale used
to obtain the harm scores is not ideal as it does not
examine all the conceivable ways in which a substance
may cause harm and is limited to nine criteria. Also
although the physical harm of drugs tends to be well
defined, that is, acute and chronic toxicity and addictive
potency, in contrast the spectrum of social harm tends to
be rather less so which may hamper the objective rating
of the social harms for drugs. Some of the social harms,
which are applicable to one drug, may not necessarily be
transferrable to another drug, which has different
properties, for example, sedative versus stimulant. There
is no method of applying a differential weighting to each
parameter of harm, and it is clear that some criteria are
more important expressions of harm than others. Nutt
et al6 attempted to address these issues using multi-
criterion decision analysis, with 16 criteria for rating
harm and a weighting score out of 100 for each criterion.
This approach increased the differentiation between the
Figure 1 Diagrammatic
representation of the ranking
of personal harm scores for
each drug.
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Figure 2 Diagrammatic
representation of the ranking of
social harm scores for each drug.
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most and least harmful drugs, and here alcohol rated as
the most harmful with heroin second and tobacco sixth.
A problem with this format of harm ratings is that it does
not take account of availability of the substance in
question, for example, that alcohol might be highly
ranked due to its low cost and widespread availability. It
is also recognised that caution must be taken in making
comparisons between legal substances and illegal ones as
substances such as alcohol, nicotine and volatile agents
are far more widely available, arguably particularly
affecting social harm. Another limitation of the present
study is that our scale measures only harm and does not
look at perceived or actual benefits to the user, which
motivated the use in the first place.
The high rankings of alcohol and tobacco in this study
reflect the common recognition that chronic use of
alcohol and tobacco cause illness and death, contrib-
uting to 90% of drug-related deaths in the UK. Every
year in the UK, tobacco smoking causes around 100 000
premature deaths, reducing average life expectancy in
regular smokers by 10 years,7 with population-based
studies suggest that smoked tobacco is the most addictive
commonly used drug. Alcohol is a growing problem in
Scotland where there is one of the fastest growing rates
of liver cirrhosis in the world, having doubled since 1990
and being twice that of England and Wales.8 Alcohol
misuse is also known to be a risk factor for suicide, and
the National Confidential Inquiry9 into suicides indi-
cated that 58% of individuals dying by suicide in Scot-
land had a history of alcohol misuse and in 17% alcohol
dependence was the primary diagnosis. The report also
shows that there is a substantially higher rate of homi-
cides and suicides in Scotland compared with England
and Wales, which can be largely attributed to high levels
of alcohol and drug misuse, both in the general popu-
lation and among people with mental health problems.
Cause and effect cannot be attributed here though, as
the pathways to suicide and to homicide are complex
and multiple. In this study, alcohol was the only drug to
rate higher on social harm than personal harm
reflecting the enormous burden to the healthcare
system posed by alcohol and also the negative effects on
rates of crime, work place absences and on family life
including domestic violence.
Interestingly, cannabis was ranked as the least harmful
drug by the Scottish addiction experts. This differs from
both Nutt’s work and the Dutch study where it was
ranked as 11th and 12th, respectively. It is not clear why
there would be such a variation in scores for cannabis,
although at the time of survey the use of high potency
cannabis was not yet widespread in Scotland. One reason
may be the differences in the panel of experts. Our study
examined the views of clinicians and addiction workers,
whereas the other panels included toxicologists, phar-
macists and experts from a legal background who would
have a different experience of working with cannabis.
Other explanations may be that despite cannabis being
commonly used in Scotland, individuals who misuse
cannabis present less frequently requesting help to
addiction services than with other drugs of abuse and
that addictions specialists do not usually see cannabis
addiction with comorbid psychotic illness and how can
one exacerbate the other.
Alcohol and drug misuse is an immense and highly
complex challenge for policymakers in Scotland.
Historically, illicit drug misuse has been linked with the
criminal justice system and the system of classification
currently in use reflects this. This study demonstrates,
similar to both of Nutt’s studies, that the legality of
a substance does not reflect its potential for harm. Just
because a substance is legal, it does not mean that it is
safe to use. This has been highlighted recently with the
reclassification of some of the so-called ‘legal highs’.
Recent work looking a mephedrone in particular have
shown that it has a considerable harm profile to both
physical10 and mental health11 and that making
a substance illegal does not necessarily reduce its usage
and may only act to drive up the price.12 The burgeoning
evidence of the harm caused by tobacco and alcohol
would also suggest that from a scientific perspective
Figure 3 Diagrammatic
representation of the ranking
of combined scores for harm.
Combined (total) harm
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these drugs are currently misclassified and that a new
method for ranking drug harm, which could guide
policies and public health strategies, is required, with
many in the scientific and medical community feeling
that this should be separated from the criminal justice
system and associated penalties. Any new system would
also have to address the issue of personal choice and
responsibility in using substances and examine the
context in which they are being used. Increasing public
awareness of the potential for harm of all the drugs
examined whether legal or illegal and finding ways of
reducing the demand for psychoactive substances should
be the focus rather than imposing harsh penalties for
their use.
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